Home › Funds › Pale Fire Capital SE › RARE

Pale Fire Capital SE position in RARE

ULTRAGENYX PHARMACEUTICAL IN · Health Care

Pale Fire Capital SE reported holding 23,214 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN) in its Q3 2026 13F filing — a position valued at US$349K, representing 0.03% of its reported portfolio and ranking #40 among its reported holdings. Pale Fire Capital SE has disclosed RARE holdings in 5 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)23.21K sh
Reported value held$348.91K
Portfolio Weight0.03%
First reportedQ2 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Pale Fire Capital SE's RARE position evolved

Pale Fire Capital SE first disclosed a stake in RARE in Q2 2025 at 5,600 shares (US$204K). The position peaked in Q2 2026 at 16,514 shares, worth US$551K. Across 5 filings, Pale Fire Capital SE increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 23,214 shares valued at US$349K — an increase of 6,700 shares quarter over quarter.. Notable position changes include a 62% increase in Q1 2026 (shares rose 59% over the following quarter), a 41% increase in Q3 2026 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 5.60K $203.62K New
Q4 2025 10.21K $234.85K New
Q1 2026 16.51K $345.97K Add
Q2 2026 16.51K $551.40K Hold
Q3 2026 23.21K $348.91K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RARE and 13F data

RARE (ULTRAGENYX PHARMACEUTICAL IN) is a Health Care company. 24 other funds we track also report a position in RARE — the largest reported positions include RTW INVESTMENTS, LP (US$260.3M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M), Bellevue Group AG (US$66.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RARE

All RARE fund holders →

FAQ

How long has Pale Fire Capital SE held RARE?

Pale Fire Capital SE has disclosed RARE holdings in 5 of the last 6 reported quarters, going back to Q2 2025.

What is Pale Fire Capital SE's current position in RARE?

As of Q3 2026, Pale Fire Capital SE holds 23.21K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $348.91K, representing 0.03% of its reported portfolio and ranking #40.

Has Pale Fire Capital SE been buying or selling RARE?

In the latest 13F filing (Q3 2026), Pale Fire Capital SE increased its position in RARE. The position peaked in Q2 2026 at 16.51K shares.

Which other funds hold RARE?

Other major institutional holders of RARE include RTW INVESTMENTS, LP, FRONTIER CAPITAL MANAGEMENT CO LLC, Bellevue Group AG, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.